Insider Trading26 Jun 2026, 03:26 pm
Panacea Biotec Closes Trading Window for Q1 FY27 Results
AI Summary
Panacea Biotec Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. The window will be shut from July 01, 2026, until 48 hours after the announcement of the unaudited financial results for the quarter ending June 30, 2026. This measure is in compliance with SEBI's Prohibition of Insider Trading Regulations, 2015, to prevent potential insider trading activities. The company will inform the stock exchanges in due course about the date of the Board of Directors' meeting to approve these financial results.
Key Highlights
- Trading window closed from July 01, 2026.
- Closure is for Q1 FY27 unaudited financial results.
- Applies to designated persons and immediate relatives.
- Aims to prevent insider trading as per SEBI regulations.
- Board meeting date for results approval to be announced.
Price Impact
More from PANACEABIO